151 related articles for article (PubMed ID: 25061574)
1. Patterns of failure and prognostic factors in resected extrahepatic bile duct cancer: implication for adjuvant radiotherapy.
Koo TR; Eom KY; Kim IA; Cho JY; Yoon YS; Hwang DW; Han HS; Kim JS
Radiat Oncol J; 2014 Jun; 32(2):63-9. PubMed ID: 25061574
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy for extrahepatic bile duct cancer: Current evidences and future perspectives.
Koo T; Park HJ; Kim K
World J Clin Cases; 2019 Jun; 7(11):1242-1252. PubMed ID: 31236388
[TBL] [Abstract][Full Text] [Related]
3. Risk factors associated with locoregional failure and estimation of survival after curative resection for patients with distal bile duct cancer.
Im JH; Park JS; Yoon DS; Lee DK; Kim JW; Lee IJ
Sci Rep; 2019 Mar; 9(1):5061. PubMed ID: 30911043
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors and patterns of recurrence after curative resection for patients with distal cholangiocarcinoma.
Zhou W; Qian L; Rong Y; Zhou Q; Shan J; Li P; Shi L; Liu H; Sun X
Radiother Oncol; 2020 Jun; 147():111-117. PubMed ID: 32268230
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2012 Apr; 35(2):136-40. PubMed ID: 21325937
[TBL] [Abstract][Full Text] [Related]
6. Salvage radiotherapy for locoregionally recurrent extrahepatic bile duct cancer after radical surgery.
Kim E; Kim YJ; Kim K; Song C; Kim JS; Oh DY; Nam EM; Chie EK
Br J Radiol; 2017 Dec; 90(1080):20170308. PubMed ID: 28937265
[TBL] [Abstract][Full Text] [Related]
7. Role of adjuvant radiotherapy in extrahepatic bile duct cancer: A multicenter retrospective study (Korean Radiation Oncology Group 18-14).
Kim K; Yu JI; Jung W; Kim TH; Seong J; Kim WC; Choi JH; Park Y; Jeong BK; Kim BH; Kim TG; Kim JH; Park HJ; Shin HS; Im JH; Heo JS; Park JO; Jang JY; Oh DY; Woo SM; Lee WJ; Chie EK
Eur J Cancer; 2021 Nov; 157():31-39. PubMed ID: 34474218
[TBL] [Abstract][Full Text] [Related]
8. Extrahepatic bile duct adenocarcinoma: patients at high-risk for local recurrence treated with surgery and adjuvant chemoradiation have an equivalent overall survival to patients with standard-risk treated with surgery alone.
Borghero Y; Crane CH; Szklaruk J; Oyarzo M; Curley S; Pisters PW; Evans D; Abdalla EK; Thomas MB; Das P; Wistuba II; Krishnan S; Vauthey JN
Ann Surg Oncol; 2008 Nov; 15(11):3147-56. PubMed ID: 18754070
[TBL] [Abstract][Full Text] [Related]
9. Surgery Alone Versus Surgery Followed by Chemotherapy and Radiotherapy in Resected Extrahepatic Bile Duct Cancer: Treatment Outcome Analysis of 336 Patients.
Im JH; Seong J; Lee IJ; Park JS; Yoon DS; Kim KS; Lee WJ; Park KR
Cancer Res Treat; 2016 Apr; 48(2):583-95. PubMed ID: 26323644
[TBL] [Abstract][Full Text] [Related]
10. Postoperative radiotherapy dose correlates with locoregional control in patients with extra-hepatic bile duct cancer.
Im JH; Seong J; Lee J; Kim YB; Lee IJ; Park JS; Yoon DS; Kim KS; Lee WJ
Radiat Oncol J; 2014 Mar; 32(1):7-13. PubMed ID: 24724046
[TBL] [Abstract][Full Text] [Related]
11. Patterns and relevant factors of tumor recurrence for extrahepatic bile duct carcinoma after radical resection.
Park SW; Park YS; Chung JB; Kang JK; Kim KS; Choi JS; Lee WJ; Kim BR; Song SY
Hepatogastroenterology; 2004; 51(60):1612-8. PubMed ID: 15532789
[TBL] [Abstract][Full Text] [Related]
12. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
13. Patterns of failure after resection of extrahepatic bile duct cancer: implications for adjuvant radiotherapy indication and treatment volumes.
Choi HS; Kang KM; Jeong BK; Jeong H; Lee YH; Ha IB; Kim TG; Song JH
Radiat Oncol; 2018 May; 13(1):85. PubMed ID: 29739420
[TBL] [Abstract][Full Text] [Related]
14. Distant metastasis risk stratification for patients undergoing curative resection followed by adjuvant chemoradiation for extrahepatic bile duct cancer.
Kim K; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):81-7. PubMed ID: 22789492
[TBL] [Abstract][Full Text] [Related]
15. High expression of MMP-9 is associated with better prognosis in extrahepatic bile duct cancer patients.
Park Y; Kim K; Paik JH; Chie EK; Jang JY; Kim SW; Oh DY
Eur J Surg Oncol; 2018 May; 44(5):638-643. PubMed ID: 29422250
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylated Akt Expression as a Favorable Prognostic Factor for Patients Undergoing Curative Resection and Adjuvant Chemoradiotherapy for Proximal Extrahepatic Bile Duct Cancer.
Kim BH; Kim K; Min HS; Chie EK; Jang JY; Kim SW; Han SW; Oh DY; Im SA; Kim TY; Bang YJ; Jang JJ; Ha SW
Am J Clin Oncol; 2017 Apr; 40(2):158-162. PubMed ID: 25171299
[TBL] [Abstract][Full Text] [Related]
17. Disease recurrence patterns and analysis of clinicopathological prognostic factors for recurrence after resection for distal bile duct cancer.
Choi SB; Han HJ; Park PJ; Kim WB; Song TJ; Kim JS; Suh SO; Choi SY
Am Surg; 2015 Mar; 81(3):289-96. PubMed ID: 25760206
[TBL] [Abstract][Full Text] [Related]
18. Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy.
Yu W; Hu C; Shui Y; Wu K; Zhang L; Chen Y; Li C; Xu J; Wei Q
BMC Cancer; 2019 Nov; 19(1):1108. PubMed ID: 31727017
[TBL] [Abstract][Full Text] [Related]
19. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
[No Abstract] [Full Text] [Related]
20. Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.
Nelson JW; Ghafoori AP; Willett CG; Tyler DS; Pappas TN; Clary BM; Hurwitz HI; Bendell JC; Morse MA; Clough RW; Czito BG
Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):148-53. PubMed ID: 18805651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
